









Seith Douglas J - Insider Stock Trading - OpenInsider











Sector

All Sectors

Group by Sector


Aerospace
Agriculture
Automobile
Building
Business Services
Chemical
Electrical
Energy
Fashion
Financial
Food & Beverage
Fund
Healthcare
Household
Insurance
Machinery
Media
Metals
Mining
Other
Personal Services
Real Estate
Retail
Technology
Telecom
Transportation
Utility




Industry

All Industries

Group by Industry






Insiders
Filings


All
Purchases
Sales

CIK: 1565823 - Address: 7555 Innovation Way, Mason, OH 45040 11 results 

						Links
						


SECYahooGoogleFinvizTradingViewStockChartsStockTwitsDownload CSV 













TC
Stat
Stk
Ins
Fil
+d
+w
+m
+q
+h
+y
avg


P%ret112461032666029P%wins5010010010010010092S%ret113104-35-11-1S%wins336767675010064 




Filing Date
T Date
Ticker
IssuerInc Sector
IndIndustry
Owner
oSt
Rel
Title
T
TVal
Price
L
Qty
oc
Own
H
r2y
r1y
r6m
r3m
r6w
r3w
r7d
r3d
f1d
f1w
f1m
f3m
f6m
f1y



6/15/17 16:196/13/17ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOCOOM.d4197.2105831243D
6/15/17 16:196/13/17ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOCOOS.d-1,24321.390-58-19243D
11/16/16 16:2411/14/16ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOCOOM.d510.82700197D9045352622163-2-1-6-11
11/16/16 16:2411/14/16ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOCOOS.d-920.237-00197D9045352622163-2-1-6-11
12/7/15 16:1012/3/15ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOCOOM.d5511.06354129D3517-5-8137-1-21-6-4-24-29-14
12/7/15 16:1012/3/15ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOCOOS.d-10821.553-5-4129D3517-5-8137-1-21-6-4-24-29-14
3/6/15 16:293/4/15ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOCOOM.dm4911.86243128D122-1515-5-11-60038212539-7
3/6/15 16:293/4/15ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOCOOS.dm-64217.512-37-22128D122-1515-5-11-60038212539-7
5/8/14 16:365/6/14ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOSVP,SaleP1515.0441199M46591-32-22-12-11-681216111954
2/12/14 11:122/11/14ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOSVP,SaleM.d81.5235698D80148113409-9-1-2040-20-23-7
8/13/13 15:438/12/13ATRCAtricure, Inc.DEHealthMdEqSurgical & Medical InstrumentSeith Douglas JOHOSVP of SP969.581102061M-3241630-4-3-3-1045211365



DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing



S - SaleSale of securities on an exchange or to another person

S - Sale+OESale of securities on an exchange or to another person (after option exercise)

F - TaxPayment of exercise price or tax liability using portion of securities received from the company

P - PurchasePurchase of securities on an exchange or from another person


Return to top
Contact
Copyright © 2017 OpenInsider.com. All rights reserved.




    Douglas Seith | AtriCure , Inc. | ZoomInfo.com










 




Douglas J  Seith - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Douglas J  Seith
Check out list of companies and businesses related to Douglas J  Seith. Find out Douglas J  Seith address and contact details. View other people related to Douglas J  Seith - coworkers, colleagues, companions, etc.
Address:   

6217 CENTRE PARK DRIVE  WEST CHESTER 45069 OH




Companies related to Douglas J  Seith
CIKCompany NamePositionCompany Address0001323885AtriCure, Inc.Chief Operating Officer 7555 INNOVATION WAY  MASON 45040




Douglas J  Seith on the Web
Persons related to Douglas J  Seith - AtriCure, Inc.NamePositionCityElsa Chi  AbruzzoVP Regulatory&Clinical Affairs WEST CHESTERRICHARD M  BERKELEYBALTIMOREStephen S  CambridgeVice President; Sales WEST CHESTERCAMDEN PARTNERS STRATEGIC FUND II A LPBALTIMORECAMDEN PARTNERS STRATEGIC FUND II B LPBALTIMORECAMDEN PARTNERS STRATEGIC II LLCBALTIMOREMICHAEL H  CARRELPresident, CEO, & Director MINNEAPOLISMICHAEL H  CARRELPresident, CEO, & Director WEST CHESTERMark A  CollarDirector WEST CHESTERMark A  CollarDirector CINCINNATIMark A  CollarDirector CINCINNATIMark A  CollarDirector CINCINNATIMark A  CollarDirector CINCINNATIMark A  CollarDirector CINCINNATITimothy J  ConnorsMENLO PARKDiscovery Group I, LLC10% Owner CHICAGODavid J  DrachmanPresident and CEO WEST CHESTERDavid J  DrachmanPresident and CEO WEST CHESTERScott William  DrakeDirector COLORADO SPRINGSScott William  DrakeDirector NIWOTThomas J  EterginoVice President and CFO WEST CHESTERIRWIN  FEDERMANMENLO PARKWINSTON S  FUMENLO PARKREGINA E  GROVESDirector SAN DIEGODONALD C  HARRISONDirector PALO ALTODONALD C  HARRISONDirector INDIAN HILLDONALD C  HARRISONDirector WEST CHESTERDONALD C  HARRISONDirector WEST CHESTERDONALD C  HARRISONDirector CINCINNATIDONALD C  HARRISONDirector INDIAN HILLMichael D  HoovenDirector WEST CHESTERMichael D  HoovenDirector CINCINNATIMichael D  HoovenDirector WEST CHESTERMichael D  HoovenDirector CINCINNATIDONALD W  HUGHESBALTIMOREB KRISTINE  JOHNSONDirector MINNEAPOLISRICHARD M  JOHNSTONDirector RICHARD M  JOHNSTONDirector BATIMORERICHARD M  JOHNSTONDirector BATIMORERICHARD M  JOHNSTONDirector BATIMORERICHARD M  JOHNSTONDirector BALTIMORERICHARD M  JOHNSTONDirector BALTIMORERICHARD M  JOHNSTONDirector BALTIMORERICHARD M  JOHNSTONDirector BALTIMORERICHARD M  JOHNSTONDirector BALTIMOREALAN L  KAGANOVDirector MENLO PARKPatricia J  KennedyVP and GM, International WEST CHESTERSTEVEN M  KRAUSZMENLO PARKElizabeth D  KrellDirector HAGERSTOWNElizabeth D  KrellDirector HAGERSTOWNMark R  LanningDirector OLDENBURGMark R  LanningDirector OLDENBURGMark R  LanningDirector WEST CHESTERMark R  LanningDirector OLDENBERGMark R  LanningDirector OLDENBERGDAVID E  LIDDLEMENLO PARKJames L  LuckyVP, Regulatory Affairs and QA WEST CHESTERJames L  LuckyVP, Clinical, Regulatory & QS WEST CHESTERANDREW L  LUXSVP, Ops & Quality HUDSONANDREW L  LUXSVP, Ops & Quality WEST CHESTERGENE R  MCGREVINALPHARETTADeborah L  MorleyVP Clinical Affairs WEST CHESTERMichael R  MurphyCHICAGOJustin J  NozneskySVP, Mktg & Business Develop MASONSTUART G  PHILLIPSMENLO PARKJulie A  PitonVP Fin & Admin & CFO WEST CHESTERJulie A  PitonVP Fin & Admin & CFO WEST CHESTERFrederick  PreissVice President Operations WEST CHESTERFrederick  PreissVice President Operations WEST CHESTERMANAGEMENT GROUP VIII L L C  PRESIDIO10% Owner MENLO PARKSalvatore  PriviteraChief Technology Officer WEST CHESTERSalvatore  PriviteraVP Engineering & Product Dev WEST CHESTERKAREN P  ROBARDSDirector PLAINSBOROKAREN P  ROBARDSDirector NEW YORKJONATHAN D  ROOTMENLO PARKChristopher J  RustMENLO PARKDouglas J  SeithChief Operating Officer WEST CHESTERMaureen  ShafferVice President Marketing WEST CHESTERJon A  ShermanVP, Product Development WEST CHESTERStewart W  StrongVice President US Sales WEST CHESTERStewart W  StrongVP Global Marketing WEST CHESTERCasey M  TanseyMENLO PARKUS VENTURE PARTNERS VIII L PMENLO PARKUSVP ENTREPRENEUR PARTNERS VIII A L PMENLO PARKUSVP ENTREPRENEUR PARTNERS VIII B L PMENLO PARKUSVP VIII AFFILIATES FUND L PMENLO PARKM. Andrew  WadeSVP and CFO WEST CHESTERRichard S  WalshVice President; Sales WEST CHESTERDAVID L  WARNOCKBALTIMORESVEN  WEHRWEINDirector MINNEAPOLISNORMAN R  WELDONDirector AMELIA ISLANDROBERT S.  WHITEDirector PLYMOUTHLee R  WrubelDirector ROWAYTONLee R  WrubelDirector WEST CHESTERPHILIP M  YOUNGMENLO PARK












 









ATRC Douglas J. Seith Insider Trades for AtriCure Inc.


































Bulletin






Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































AtriCure Inc.

                  NASDAQ: ATRC
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

AtriCure Inc.



Market open
 --Real time quotes
Jul 28, 2017, 2:42 p.m.


ATRC

/quotes/zigman/96608/composite


$
24.00




Change

+1.31
+5.77%

Volume
Volume 398,149
Real time quotes








/quotes/zigman/96608/composite
Previous close

$
			22.69
		


$
				24.00
			
Change

+1.31
+5.77%





Day low
Day high
$21.95
$24.39










52 week low
52 week high

            $13.45
        

            $25.11
        


















Insider Activity


Individual




Douglas J. Seith



Mr. Douglas J. Seith is Chief Operating Officer at AtriCure, Inc.
He received his undergraduate degree from Ohio Wesleyan University.



Transactions


Date
Shares
Transaction
Value





06/30/2017
888


 
Award at $16.32 per share.


14,492


06/13/2017
58,112


 
Disposition at $21.39 per share.


1,243,016


06/13/2017
25,000


 
Derivative/Non-derivative trans. at $6.73 per share.


168,250


06/13/2017
21,100


 
Derivative/Non-derivative trans. at $6.27 per share.


132,297


06/13/2017
512


 
Derivative/Non-derivative trans. at $5.7 per share.


2,918


06/13/2017
10,000


 
Derivative/Non-derivative trans. at $10.05 per share.


100,500


06/13/2017
1,500


 
Derivative/Non-derivative trans. at $10.1 per share.


15,150


03/01/2017
9,566


 
Derivative/Non-derivative trans. at $18.95 per share.


181,276


03/01/2017
60,000


 
Award at $0 per share.


0


01/24/2017
2,387


 
Derivative/Non-derivative trans. at $15.7 per share.


37,476


12/30/2016
109


 
Award at $12.27 per share.


1,337


12/27/2016
1,710


 
Derivative/Non-derivative trans. at $19.41 per share.


33,192


11/14/2016
200


 
Derivative/Non-derivative trans. at $12.22 per share.


2,444


11/14/2016
250


 
Derivative/Non-derivative trans. at $9.7 per share.


2,425


06/30/2016
1,107


 
Award at $12.01 per share.


13,295


03/01/2016
75,000


 
Award at $0 per share.


0


03/01/2016
4,443


 
Derivative/Non-derivative trans. at $16.3 per share.


72,421


01/25/2016
2,332


 
Derivative/Non-derivative trans. at $18.43 per share.


42,979


12/31/2015
195


 
Award at $19.07 per share.


3,718


12/28/2015
1,709


 
Derivative/Non-derivative trans. at $22.53 per share.


38,504


12/03/2015
5,000


 
Disposition at $21.55 per share.


107,750


12/03/2015
5,000


 
Derivative/Non-derivative trans. at $11.06 per share.


55,300


06/30/2015
1,027


 
Award at $16.81 per share.


17,263


05/18/2015
683


 
Derivative/Non-derivative trans. at $21.9 per share.


14,958


03/05/2015
1,144


 
Derivative/Non-derivative trans. at $12 per share.


13,728


03/05/2015
3,633


 
Disposition at $17.74 per share.


64,450


03/05/2015
3,948


 
Disposition at $17.75 per share.


70,077


03/05/2015
1,000


 
Disposition at $17.72 per share.


17,720


03/05/2015
1,144


 
Disposition at $17.73 per share.


20,284


03/04/2015
3,000


 
Disposition at $17.41 per share.


52,230


03/04/2015
1,487


 
Derivative/Non-derivative trans. at $12 per share.


17,844


03/04/2015
1,513


 
Derivative/Non-derivative trans. at $11.63 per share.


17,596


03/04/2015
4,263


 
Disposition at $17.42 per share.


74,262


03/04/2015
10,700


 
Disposition at $17.44 per share.


186,608


03/04/2015
6,000


 
Disposition at $17.42 per share.


104,520


03/04/2015
3,000


 
Disposition at $17.43 per share.


52,290


03/02/2015
65,000


 
Award at $0 per share.


0


01/26/2015
2,265


 
Derivative/Non-derivative trans. at $20.07 per share.


45,459


12/31/2014
321


 
Award at $15.7 per share.


5,039


12/29/2014
1,709


 
Derivative/Non-derivative trans. at $19.13 per share.


32,694


06/30/2014
1,057


 
Award at $15.33 per share.


16,203


05/19/2014
683


 
Derivative/Non-derivative trans. at $15.72 per share.


10,737


05/06/2014
500


 
Acquisition at $15.05 per share.


7,525


05/06/2014
500


 
Acquisition at $15.03 per share.


7,515


02/11/2014
5,263


 
Derivative/Non-derivative trans. at $1.52 per share.


7,999


01/24/2014
30,000


 
Award at $0 per share.


0


12/31/2013
1,500


 
Award at $8.09 per share.


12,135


12/27/2013
1,709


 
Derivative/Non-derivative trans. at $18.93 per share.


32,352


08/12/2013
3,000


 
Acquisition at $9.58 per share.


28,740


08/12/2013
7,000


 
Acquisition at $9.58 per share.


67,060


06/30/2013
1,500


 
Award at $6.07 per share.


9,105


05/20/2013
661


 
Derivative/Non-derivative trans. at $9.05 per share.


5,983





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Michael H. Carrel 
President, Chief Executive Officer & Director




Mr. Douglas J. Seith 
Chief Operating Officer




Mr. M. Andrew Wade 
CFO, Principal Accounting Officer & Senior VP




Mr. Salvatore  Privitera 
Chief Technology Officer




Dr. Vini  Doraiswamy 
SVP-Clinical, Regulatory & Scientific Affairs




Mr. David  Francischelli 
Vice President-Research & Development




Ms. Shana R. Zink 
Vice President-Clinical Affairs




Dr. Andrew L. Lux 
Senior VP-Operations & Quality Assurance




Mr. Karl  Dahlquist 
Chief Compliance Officer, VP-Legal & Regulatory




Mr. Michael J. Rogge 
VP-Professional Education & Scientific Affairs




Mr. Justin J. Noznesky 
Senior VP-Marketing & Business Development




Ms. Tonya  Austin 
Vice President-Human Resources




Mr. Dick M. Johnston 
Chairman




Ms. B. Kristine Johnson 
Independent Director




Ms. Regina  Groves 
Independent Director




Mr. Sven A. Wehrwein 
Independent Director




Mr. Mark R. Lanning 
Independent Director




Mr. Scott William Drake 
Independent Director




Dr. Elizabeth D. Krell 
Independent Director




Mr. Mark A. Collar 
Independent Director




Mr. Robert S. White 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




2:43 PM EDT
July 28, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
2:39pGold tallies third weekly gain on North Korea news, weaker dollar 
2:39pSept. WTI oil climbs 67 cents, or 1.4%, to settle at $49.71/bbl
2:39pWTI oil ends at highest since late May, up 8.6% for the week
2:35pWhat Trump could do to make Obamacare ‘implode’
2:32pAre you prepared for retirement? 10 questions to ask yourself
2:32p10 questions to ask yourself before you buy — or sell — a house
2:24pWage-rebound story takes another hit after drab ECI report
2:24pStock market lower after Amazon disappointment, but pares losses
2:21pPeople aren’t saving for retirement and that’s why myRA is shutting down 
2:15pHow a college degree is like a Social Security check
2:13pOpinion Journal: The Trump Tax Reform Agenda
2:10pRetire early? Sounds great on paper but it could cost a lot
2:07p101 things to do in London for $20 or less
2:05pWho are the beneficiaries of a 401(k) if my wife and I die at the same time?
2:04pCharlie Gard, British baby at center of controversy, has died
2:03pUnder Armour's stock's low price doesn't mean it is cheap
2:00pRetirement Weekly news and analysis
1:56pFloyd Mayweather says he is going to make bank off an ICO
1:54pFoxconn’s history of broken promises casts a shadow on Wisconsin news
1:52pGoodyear stock stumbles 11% after quarter ‘played out differently than we expected’
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,807.25

+10.70
+0.05%





nasdaq

/quotes/zigman/12633936/realtime
6,375.30

-6.89
-0.11%





s&p 500

/quotes/zigman/3870025/realtime
2,470.01

-5.41
-0.22%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Track insider buy and sell







 Seith Douglas J,  officer (Chief Operating Officer) of ATRC - 
       Past Performance as of 07/28/17. Total 16 
      Records. 
Link to Thomson Financial












Buy(P) /Sell(S)
P/S date
Filed Date
Company
Symbol
Insider
Relationship
Share Amt.
Unit Price
Total Proceeds
Shares Owned
Return(1m)
Details


S
2017-06-13
2017-06-15 16:19:59
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
58,112
$21.39
$1,243,020.00
239,479
N/A
view


S
2016-11-14
2016-11-16 16:29:10
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
450
$20.23
$9,103.50
193,033
N/A
view


S
2015-12-03
2015-12-07 16:11:10
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
5,000
$21.55
$107,750.00
125,215
N/A
view


S
2015-03-04
2015-03-06 16:30:51
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
3,000
$17.43
$52,290.00
154,415
-24.38%
view


S
2015-03-04
2015-03-06 16:30:51
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
6,000
$17.42
$104,520.00
148,415
-24.45%
view


S
2015-03-04
2015-03-06 16:30:51
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
10,700
$17.44
$186,608.00
137,715
-24.31%
view


S
2015-03-04
2015-03-06 16:30:51
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
4,263
$17.42
$74,261.50
133,452
-24.45%
view


S
2015-03-04
2015-03-06 16:30:51
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
3,000
$17.41
$52,230.00
133,452
-24.53%
view


S
2015-03-05
2015-03-06 16:30:51
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
3,633
$17.74
$64,449.40
129,819
-22.21%
view


S
2015-03-05
2015-03-06 16:30:51
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
1,144
$17.73
$20,283.10
129,819
-22.28%
view


S
2015-03-05
2015-03-06 16:30:51
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
1,000
$17.72
$17,720.00
128,819
-22.35%
view


S
2015-03-05
2015-03-06 16:30:51
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (Chief Operating Officer)
3,948
$17.75
$70,077.00
124,871
-22.14%
view


P
2014-05-06
2014-05-08 16:38:38
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (SVP, Sales and Marketing)
500
$15.03
$7,515.00
95,694
10.51%
view


P
2014-05-06
2014-05-08 16:38:38
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (SVP, Sales and Marketing)
500
$15.05
$7,525.00
3,500
10.37%
view


P
2013-08-12
2013-08-13 15:44:39
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (SVP of Sales and Marketing)
7,000
$9.58
$67,060.00
58,240
3.76%
view


P
2013-08-12
2013-08-13 15:44:39
AtriCure, Inc.
ATRC
Seith Douglas J
 officer (SVP of Sales and Marketing)
3,000
$9.58
$28,740.00
3,000
3.76%
view


* Filed by insider as open market transaction, but marked as private transaction by insidercow's proprietary method












Douglas J. Seith - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Douglas J. Seith
Chief Operating Officer at AtriCure, Inc.


View Full Profile
Are you Douglas J. Seith? Claim your profile


 


Sign up for Equilar Atlas and view Douglas J. Seith's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Douglas J. Seith's  network and community.
												FOLLOW changes in Douglas J. Seith's employment and money-in-motion.
												CONNECT with Douglas J. Seith through your network of contacts.
												








Douglas J. Seith's Executive Work History


Current


Chief Operating Officer, 
AtriCure, Inc.


Past
To view Douglas J. Seith's complete executive work history, sign up now
Age
51

 
 


Douglas J. Seith's Biography



Douglas J. Seith has served as our Chief Operating Officer since January 2015, having previously served as our Senior Vice President, Sales and Marketing from 2013 to 2014 and as our Vice President, United States Sales from 2011 to 2013. Since joining AtriCure in 2004 as a Regional Sales Leader, Mr. Seith has held a variety of progressive sales and sales leadership positions, including Area Director roles. Mr. Seith has over 25 years of cardiology and general surgery sales and sales leadership experience. Prior to joining AtriCure, Mr. Seith held sales leadership and/or sales positions with A-Med/EmoblX, Inc., where he was the Vice President  ...
(Read More)

			Douglas J. Seith has served as our Chief Operating Officer since January 2015, having previously served as our Senior Vice President, Sales and Marketing from 2013 to 2014 and as our Vice President, United States Sales from 2011 to 2013. Since joining AtriCure in 2004 as a Regional Sales Leader, Mr. Seith has held a variety of progressive sales and sales leadership positions, including Area Director roles. Mr. Seith has over 25 years of cardiology and general surgery sales and sales leadership experience. Prior to joining AtriCure, Mr. Seith held sales leadership and/or sales positions with A-Med/EmoblX, Inc., where he was the Vice President of Sales, Heartport, Inc., Scimed Life Systems, a division of Boston Scientific, Inc. and Automated Instruments (a division of Unites States Surgical Corporation). Mr. Seith received his B.A. from Ohio Wesleyan University.
		
Source: AtriCure, Inc. on 04/12/2017
		
	

 






Sign up for Equilar Atlas and view Douglas J. Seith's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Douglas J. Seith. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Douglas J. Seith's  network and community.
												FOLLOW changes in Douglas J. Seith's employment and money-in-motion.
												CONNECT with Douglas J. Seith through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Douglas J. Seith


















Douglas J. Seith's Connections (18)





Sign up now to view Douglas J. Seith's 18 connections »









Mark A. Collar
Former Board Member, AtriCure, Inc.









Regina E. Groves
Board Member, AtriCure, Inc.









Stewart W. Strong
Former Vice President, Global Marketing, AtriCure, Inc.









Andrew L. Lux
Senior Vice President, Operations and Quality, AtriCure, Inc.









Sven A. Wehrwein
Board Member, SPS Commerce, Inc.









Robert S. White
Dir., President and Chief Executive Officer, Entellus Medical, Inc.









Donald C. Harrison
Former Board Member, AtriCure, Inc.









Patricia J. Kennedy
Former Vice President and General Manager, International, AtriCure, Inc.









Michael D. Hooven
Former Board Member, AtriCure, Inc.









James L. Lucky
Former Vice President, Regulatory Affairs and Quality Systems, AtriCure, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
























Management



















































Skip to main content







Search form

Search 


United States / International



 

















AtriCure's management team consists of proven leaders, respected innovators and caring, compassionate individuals.
 
 




Michael H. Carrel 
President and Chief Executive Officer

Tonya Austin
Vice President, Human Resources

Justin Noznesky
Senior Vice President, Marketing and Business Development

Shana Zink
Vice President, Clinical Affairs
 




M. Andrew Wade
Senior Vice President and Chief Financial Officer

David Francischelli
Vice President, Research and Development

Vini Doraiswamy, PhD
Senior Vice President, Clinical, Regulatory, and Scientific Affairs

Michael J. Rogge
Vice President, Professional Education
 




Douglas J. Seith
Chief Operating Officer

Andrew L. Lux, PhD
Senior Vice President, Operations and Quality

Karl Dahlquist
Vice President, Legal and Chief Compliance Officer
Salvatore (Sam) Privitera
Chief Technical Officer
 



 


















RF Ablation, Pacing and Sensing
Bipolar RF Clamps
Versapolar RF with Suction
Minimally Invasive
Linear Pens and Probes
Capital Equipment

Soft Tissue Dissection
Devices

 









Cryo
Cryoablation Probes
Cryoanalgesia Probe
Capital Equipment

Left Atrial Appendage Management
AtriClip Devices
AtriClip PRO Devices
Accessories

 











Cart Configurations
Basic Cart
Simple Cart
Fusion Cart

Estech Valve Instrumentation
Access
LiV Instruments

 









Instructions for Use (IFUs)
USA
 
 
 
 















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












Seith Douglas J Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      Seith Douglas J
                    

•   WEST CHESTER, OH
                      
How do I update this listing?




                                             Seith Douglas J is based out of West Chester.    WhaleWisdom has at least 3 insider transactions (Form 3,4,5) in our database for Seith Douglas J. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from Seith Douglas J, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




seith douglas j


6217 CENTRE PARK DRIVE

WEST CHESTER
OH
                                                        
                                                    45069


                                                      Business Phone:
                                                      513-755-4107
SEC SIC CODE:3841-SURGICAL & MEDICAL INSTRUMENTS & APPARATUS







Recent SEC Filings




4 filed on 07/05/2017
4 filed on 06/15/2017
4 filed on 03/03/2017
4 filed on 01/26/2017
4 filed on 01/04/2017
4 filed on 12/29/2016
4 filed on 11/16/2016
4 filed on 07/05/2016
4 filed on 03/03/2016
4 filed on 01/27/2016
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free

















  Atricure, Inc. (ATRC) Files Form 4 Insider Selling : Douglas J Seith  Sells  58,112 Shares – Energy Index          Search       Atricure, Inc. (ATRC) Files Form 4 Insider Selling : Douglas J Seith  Sells  58,112 Shares       Stephanie Haddix    June 19, 2017         Atricure, Inc. (ATRC): Douglas J Seith , Chief Operating Officer of Atricure, Inc.  sold 58,112 shares on Jun 13, 2017. The Insider selling transaction was reported by the company on Jun 15, 2017 to the Securities and Exchange Commission. The shares were sold at $21.39 per share for a total value of $1,243,015.62  , the company said in a SEC Form 4 Filing.Other Insider transactions have been reported by the company according to SEC Form 4, on May 17, 2017, Elizabeth D Krell  (director) sold 10,000 shares at $21.44 per share price.On May 9, 2017, Michael D Hooven  (director) sold 10,000 shares at $22.08 per share price.Also, On Mar 21, 2017, Andrew L Lux  (SVP, Ops & Quality) sold 20,000 shares at $18.85 per share price.On Nov 16, 2016, Douglas J Seith  (Chief Operating Officer) sold 450 shares at $20.23 per share price.AtriCure: On Tuesday, May 30, 2017 heightened volatility was witnessed in AtriCure which led to swings in the share price. The shares opened for trading at $20.93 and hit $21.9 on the upside , eventually ending the session at $20.96, with a gain of 1.21% or 0.25 points. The heightened volatility saw the trading volume jump to 1,73,809 shares. The 52-week high of the share price is $23.95 and the company has a market cap of $712 M . The 52-week low of the share price is at $13.45.Company has been under the radar of several Street Analysts.AtriCure is Resumed by Piper Jaffray to Overweight. The Rating was issued on May 30, 2017.AtriCure Inc. is a medical device company providing atrial fibrillation (Afib) solutions. The Company has three primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The Company’s Isolator Synergy System which includes its Isolator Synergy clamps generator and switchbox is used for the treatment of persistent and long-standing persistent Afib in patients who are undergoing open concomitant coronary artery bypass grafting and valve replacement or repair. The cryoICE cryosurgery product line offers a range of both single use and reusable cryoablation devices. The AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart’s left atrial appendage (LAA). Its radiofrequency (RF) ablation products are indicated for the ablation of cardiac tissue. The Company sells enabling technologies including its Lumitip dissectors and Endoscopic Technologies Inc.’s (Estech) line of reusable cardiac surgery instruments.     Stephanie HaddixFor corrections, feedback and news tipcs, email Stephanie.Haddix@energyindexwatch.comYou might also likeBankfinancial Corp (BFIN) Files Form 4 Insider Selling : Paul A Cloutier  Sells  10,000 Shares Bankfinancial Corp (BFIN): Paul A Cloutier ,…Opko Health, Inc. (OPK) Files Form 4 Insider Buying : Gamma Investments Trust Frost  Buys  1,800 Shares Opko Health, Inc. (OPK): Gamma Investments Trust…Chesapeake Energy Corp (CHK) Files Form 4 Insider Buying : R Brad Martin  Buys  20,400 Shares Chesapeake Energy Corp (CHK): R Brad Martin…Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *   Previous PostHancock Holding Co (HBHC) Files Form 4 Insider Selling : Robert W Roseberry  Sells  2,038 Shares Next PostDelek Us Holdings, Inc. (DK) Files Form 4 Insider Selling : Assi Ginzburg  Sells  4,951 Shares Latest Earning ReleasesThe Big Earnings of Chipotle Mexican Grill Were Overshadowed by the Data BreachDespite its Sales Spiraling Down H&M Launches a New Label- ArketRevenue Update on AdCare Health Systems(NYSEMKT:ADK)Revenue Update on Eleven Biotherapeutics Inc(NASDAQ:EBIO)     The Demand for Cloud and SSD Are Now the Prime Growth Engines for Micron As WellAlaska Airlines Planning to Absorb Virgin America by 2019Andrew Puzder Decides to Leave CKE Restaurants HoldingsSoftbank Goes Soft on Wework and Invests $300 MillionMore Departures in Uber as Two Executives LeaveVolkswagen and Audi Headquarters Raided by German Authorities      